Melatonin supplementation efficacy
Pro Research Analysisby 
Searched over 200M research papers
Melatonin Supplementation Efficacy in Sleep Disorders
Research shows that melatonin supplementation can improve certain aspects of sleep quality, but its effects vary depending on the population and specific sleep parameters measured. In middle-aged adults with primary insomnia, melatonin significantly reduced early wake time and altered some sleep stage percentages, but did not significantly improve overall insomnia symptoms or subjective sleep quality scores compared to placebo. Importantly, no serious adverse events were reported, indicating melatonin is safe for short-term use in this group . In patients with sleep disturbances following traumatic brain injury, melatonin supplementation improved subjective sleep quality, sleep efficiency, vitality, and mental health, and reduced anxiety and fatigue, but did not significantly affect sleep onset latency or daytime sleepiness . A broader meta-analysis found that melatonin reduces sleep onset latency and increases total sleep time, with optimal effects at a dose of 4 mg/day taken about three hours before bedtime .
Melatonin for Migraine Prophylaxis
Melatonin supplementation has shown promise in reducing the frequency of episodic migraine attacks. A network meta-analysis found that 3 mg of immediate-release melatonin at bedtime was associated with the greatest improvement in migraine frequency and a high response rate compared to placebo and other pharmacologic interventions, suggesting a potential role for melatonin in migraine prevention .
Melatonin’s Impact on Inflammation and Oxidative Stress
Multiple studies indicate that melatonin supplementation can reduce inflammation and oxidative stress. Meta-analyses have shown that melatonin significantly decreases pro-inflammatory cytokines such as TNF-α and IL-6, and improves oxidative stress markers by increasing antioxidant capacity and reducing markers like malondialdehyde (MDA) 45. These effects are relevant for chronic disease management, as inflammation and oxidative stress are common underlying factors.
Melatonin and Metabolic Health: Diabetes and Obesity
Melatonin supplementation has demonstrated beneficial effects on metabolic parameters in people with diabetes. A meta-analysis of randomized clinical trials found that melatonin significantly reduced fasting blood glucose, glycated hemoglobin, and insulin resistance compared to placebo . In the context of obesity, melatonin appears to support glycemic control, modulate adipose tissue activity, and improve lipid metabolism, although more research is needed to clarify its full therapeutic potential and optimal dosing in this population .
Melatonin in Multiple Sclerosis (MS)
The evidence for melatonin supplementation in multiple sclerosis is mixed. Some studies report that melatonin reduces oxidative stress and pro-inflammatory cytokines in patients with relapsing-remitting MS, but do not find significant improvements in clinical outcomes such as disability or relapse rates 910. While melatonin appears safe and may improve sleep and fatigue in some MS patients, current data are insufficient to recommend routine use for MS management .
Conclusion
Melatonin supplementation is generally safe and can be effective for improving certain sleep parameters, reducing migraine frequency, lowering inflammation and oxidative stress, and supporting metabolic health in diabetes and obesity. Its benefits in multiple sclerosis are less clear, with more research needed. Optimal dosing and timing are important for maximizing efficacy, especially for sleep-related outcomes. Overall, melatonin is a promising supplement for specific conditions, but its effects can vary depending on the individual and the health issue being addressed.
Sources and full results
Most relevant research papers on this topic